Social media

Javascript is required to use HSE website social media functionality.

Pharmaceutical workers exposed to hazardous substance

A Swindon pharmaceutical company has been fined after a number of its employees were sensitised to a potent substance and developed allergic contact dermatitis.

HSE prosecuted Catalent U.K. Swindon Zydis Limited after at least ten employees developed the skin condition when working with Olanzapine. The substance is an active ingredient in one of the most commonly prescribed antipsychotic drugs and is a known cause of allergic contact dermatitis.

View press release ‘Pharmaceutical workers exposed to hazardous substance’